Benafif, Sarah
Jones, Ann-Britt http://orcid.org/0000-0001-6565-4556
Merson, Susan
Rageevakumar, Reshma
McGrowder, Eva
Tyler, Matthew
Cafferty, Fay
Hogben, Matthew
Hussain, Nafisa
Bancroft, Elizabeth
Reid, Alison
Wakerell, Sarah
Karlsson, Questa
Saunders, Edward
Whitmore, Ian
Sorensen, Karina Dalsgaard
Dennis, Nening
Black, Evie
Wood, Angela
Richards, Kate
Lees, Kathryn
Perna, Carla
Falconer, Alison
Mills, Jamie
Hughes, Robert
Kumar, Shiyam
Mikropoulos, Christos
Burnett, Stephanie
Attard, Gerhardt
Hall, Emma
Kote-Jarai, Zsofia
Eeles, Ros
Funding for this research was provided by:
FP7 Ideas: European Research Council (ERC-2013-AdG-339208, ERC-2013-AdG-339208, ERC-2013-AdG-339208, ERC-2013-AdG-339208, ERC-2013-AdG-339208, ERC-2013-AdG-339208, ERC-2013-AdG-339208, ERC-2013-AdG-339208)
Novo Nordisk Foundation Tandem Programme (NNF20C0059410, NNF20C0059410, NNF20C0059410, NNF20C0059410, NNF20C0059410, NNF20C0059410, NNF20C0059410)
Article History
Received: 19 September 2023
Revised: 8 November 2023
Accepted: 19 November 2023
First Online: 15 February 2024
Competing interests
: RE has received honoraria from GU-ASOC, Janssen, University of Chicago, ESMO, Astra Zeneca UK Ltd, DFCI and conducts private practice at RMH, 90S Sloane Street, 280 Kings Road. EH has received honoraria from Accuray Inc, Varian Medical Systems Inc, Astra Zeneca, Janssen-Clag, Bayer, Roche Products Ltd and Merck Sharp & Dohm. KDS has received honoraria (outside of this submitted study) from Sanofi, Astra Zeneca and MSD. All other authors declare no competing interests.
: The study is sponsored by The Institute of Cancer Research (ICR), has regulatory approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA); ethics approval was provided by the London-Chelsea research Ethics Committee (16/LO/1686). Informed consent was obtained for all participants. This study was performed in accordance with the Declaration of Helsinki.